According to MarketBeat, Amgen presently has an average rating of “Moderate Buy” and an average target price of $285.

Source: https://www.etfdailynews.com/2023/12/27/amgen-inc-nasdaqamgn-stake-raised-by-opal-wealth-advisors-llc/

Amgen is in the hunt with olpasiran, a gene-silencing drug licensed from Arrowhead Pharmaceuticals that has reached late-stage clinical development.

Source: https://medcitynews.com/2023/06/eli-lilly-cardiovascular-disease-in-vivo-gene-editing/

As a group, equities analysts anticipate that Amgen Inc. will post 17.73 earnings per share for the current year.

Source: https://www.americanbankingnews.com/2023/04/11/876-shares-in-amgen-inc-nasdaqamgn-acquired-by-annex-advisory-services-llc-2.html

As a group, equities research analysts forecast that Amgen Inc. will post 17.62 earnings per share for the current fiscal year.

Source: https://www.americanbankingnews.com/2023/01/10/aspiriant-llc-grows-stock-position-in-amgen-inc-nasdaqamgn.html

Assenagon Asset Management S.A. raised its stake in shares of Amgen Inc. () by 1,669.5% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission.

Source: https://www.americanbankingnews.com/2023/01/07/amgen-inc-nasdaqamgn-shares-acquired-by-assenagon-asset-management-s-a.html

Banque Pictet & Cie SA’s holdings in Amgen were worth $1,211,000 as of its most recent SEC filing.

Source: https://www.americanbankingnews.com/2023/07/20/banque-pictet-cie-sa-lowers-stock-holdings-in-amgen-inc-nasdaqamgn.html

Biotechnology giant Amgen Inc. began talks with investors Tuesday about a potential jumbo bond deal to help finance its roughly $28 billion acquisition of Dublin-based Horizon Therapeutics, according to the company and deal documents.

Source: https://biztoc.com/x/43716f8233e04893?ref=ff

California Public Employees Retirement System grew its stake in shares of Amgen by 1.6% in the third quarter.

Source: https://www.americanbankingnews.com/2023/04/02/amgen-inc-nasdaqamgn-shares-acquired-by-park-avenue-securities-llc.html

Credit Suisse Group dropped their target price on shares of Amgen from $240.00 to $220.00 and set an “underperform” rating on the stock in a research report on Wednesday, February 1st.

Source: https://www.etfdailynews.com/2023/02/24/amgen-inc-nasdaqamgn-shares-sold-by-keeley-teton-advisors-llc/

Envestnet Asset Management Inc. raised its position in Amgen by 216.1% during the first quarter.

Source: https://www.etfdailynews.com/2023/10/12/congress-asset-management-co-ma-sells-212-shares-of-amgen-inc-nasdaqamgn/

Federated Hermes Inc. boosted its holdings in shares of Amgen by 23.3% in the second quarter.

Source: https://www.etfdailynews.com/2023/04/12/amgen-inc-nasdaqamgn-stock-holdings-decreased-by-bdo-wealth-advisors-llc/

Finally, Advisor Partners II LLC grew its position in Amgen by 16.6% in the fourth quarter.

Source: https://www.americanbankingnews.com/2023/06/18/amgen-inc-nasdaqamgn-shares-purchased-by-radnor-capital-management-llc.html

Finally, Argus decreased their price target on shares of Amgen from $300.00 to $270.00 in a research note on Monday, February 6th.

Source: https://www.etfdailynews.com/2023/02/24/amgen-inc-nasdaqamgn-shares-sold-by-keeley-teton-advisors-llc/

Finally, Jefferies Financial Group reaffirmed a “buy” rating and set a $310.00 price target on shares of Amgen in a research note on Thursday, October 12th.

Source: https://www.etfdailynews.com/2023/12/16/franklin-street-advisors-inc-nc-purchases-3455-shares-of-amgen-inc-nasdaqamgn/

Finally, KB Financial Partners LLC acquired a new position in Amgen in the 1st quarter valued at about $45,000.

Source: https://www.etfdailynews.com/2023/10/29/amgen-inc-nasdaqamgn-shares-acquired-by-eversource-wealth-advisors-llc/

Finally, Lumature Wealth Partners LLC grew its stake in shares of Amgen by 51.1% in the first quarter.

Source: https://www.etfdailynews.com/2023/12/29/merrion-investment-management-co-llc-sells-200-shares-of-amgen-inc-nasdaqamgn/

Finally, Lumature Wealth Partners LLC increased its holdings in Amgen by 51.1% in the first quarter.

Source: https://www.etfdailynews.com/2023/12/13/amgen-inc-nasdaqamgn-shares-purchased-by-rehmann-capital-advisory-group/

Finally, Price T Rowe Associates Inc. MD lifted its holdings in Amgen by 158.0% during the fourth quarter.

Source: https://www.etfdailynews.com/2023/11/12/institutional-family-asset-management-llc-increases-holdings-in-amgen-inc-nasdaqamgn/

Following this news, the price of Amgen common stock fell by more than 6%.

Source: https://www.prnewswire.com/news-releases/amgn-class-action-reminder-kessler-topaz-meltzer--check-llp-reminds-amgen-inc-investors-of-securities-fraud-class-action-lawsuit-301781539.html

Glassy Mountain Advisors Inc. acquired a new stake in shares of Amgen in the 4th quarter valued at about $26,000.

Source: https://www.americanbankingnews.com/2023/04/14/amgen-inc-nasdaqamgn-shares-acquired-by-ae-wealth-management-llc.html